These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11817007)
1. Lodoxamide as adjuvant therapy in patients with dry eye. Petricek I; Pokupec R; Petricek G; Salopek-Rabatić J Coll Antropol; 2001; 25 Suppl():149-52. PubMed ID: 11817007 [TBL] [Abstract][Full Text] [Related]
2. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital. Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy]. Nicoară S Oftalmologia; 2001; 52(2):81-4. PubMed ID: 11771108 [TBL] [Abstract][Full Text] [Related]
4. [An efficacy study of lodoxamide treatment in allergic eye lesions]. Giuri S; Munteanu GH Oftalmologia; 2000; 50(1):68-76. PubMed ID: 11021110 [TBL] [Abstract][Full Text] [Related]
5. Lodoxamide versus spaglumic acid: a comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by Parietaria pollen. Purello D'Ambrosio F; Gangemi S; Ricciardi L; Cuzzocrea S; Di Lorenzo G Allergol Immunopathol (Madr); 1997; 25(5):233-7. PubMed ID: 9395007 [TBL] [Abstract][Full Text] [Related]
6. [Comparison of local acetylcysteine and artificial tears in the management of dry eye syndrome]. Pokupec R; Petricek I; Sikić J; Bradić M; Popović-Suić S; Petricek G Acta Med Croatica; 2005; 59(4):337-40. PubMed ID: 16334742 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of lodoxamide in vernal keratoconjunctivitis. Das D; Khan M; Gul A; Alam R J Pak Med Assoc; 2011 Mar; 61(3):239-41. PubMed ID: 21465936 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the efficacy and safety of lodoxamide in patients with allergic eye diseases]. Dekaris I; Gabrić N; Lazić R; Bosnar D; Cima I; Stipić A Acta Med Croatica; 2002; 56(3):93-8. PubMed ID: 12630339 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis. Avunduk AM; Avunduk MC; Kapicioglu Z; Akyol N; Tavli L Ophthalmology; 2000 Jul; 107(7):1333-7. PubMed ID: 10890862 [TBL] [Abstract][Full Text] [Related]
10. Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD. Ogawa Y; Dogru M; Uchino M; Tatematsu Y; Kamoi M; Yamamoto Y; Ogawa J; Ishida R; Kaido M; Hara S; Matsumoto Y; Kawakita T; Okamoto S; Tsubota K Bone Marrow Transplant; 2010 Mar; 45(3):565-9. PubMed ID: 19633693 [TBL] [Abstract][Full Text] [Related]
11. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment. Wilson SE; Perry HD Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial. Avunduk AM; Tekelioglu Y; Turk A; Akyol N Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis. Salib GM; McDonald MB; Smolek M J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis. Oguz H; Bitiren M; Aslan OS; Ozardali I Acta Med Okayama; 1999 Jun; 53(3):123-6. PubMed ID: 10410789 [TBL] [Abstract][Full Text] [Related]
15. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500 [TBL] [Abstract][Full Text] [Related]
16. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Barber LD; Pflugfelder SC; Tauber J; Foulks GN Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833 [TBL] [Abstract][Full Text] [Related]
17. A clinical study of the efficacy of topical corticosteroids on dry eye. Yang CQ; Sun W; Gu YS J Zhejiang Univ Sci B; 2006 Aug; 7(8):675-8. PubMed ID: 16845723 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis. Bonini S; Schiavone M; Bonini S; Magrini L; Lischetti P; Lambiase A; Bucci MG Ophthalmology; 1997 May; 104(5):849-53. PubMed ID: 9160033 [TBL] [Abstract][Full Text] [Related]
19. [A new therapy concept for the treatment of dry eye--the usefulness of phospholipid liposomes]. Lee S; Dausch S; Maierhofer G; Dausch D Klin Monbl Augenheilkd; 2004 Oct; 221(10):825-36. PubMed ID: 15499517 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease. Rao SN; Rao RD Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]